StockData
Onconetix, Inc. logo

Onconetix, Inc. (ONCO) stock

ONCONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$3.00+0.09 (+3.09%)

Close on Nov 17, 2026Market cap $11.85MP/E –Yield –

Onconetix price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Onconetix's price to book ratio was 1.1× on Nov 11, 2026, against 250.1× a year earlier. Over the last 3 years it ranged from 0.0× to 399.1×, with a median of 172.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.1×−288.3
2025Oct 31, 2025289.4×+212.1
2024Dec 31, 202477.3×−95.2
2023Dec 29, 2023172.4×−141.8
2022Dec 30, 2022314.2×–

More Onconetix figures

See a number that looks wrong?